Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-039055

Chief Development Officer sold 1,545 shares at an average $15.01 ($23,198)

  • Chief Development Officer acquired 1,239 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Curley Joanne · Chief Development Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-22 Exercise or conversion : show line 1 in the form +1,239 $6.37 $7,896 25,233 D
2022-06-22 Sale : show line 2 in the form −1,239 $15.01 $18,603 23,994 D
2022-06-22 Sale : show line 3 in the form −306 $15.02 $4,595 23,688 D
Open-market sales · 1,545 sh · avg $15.01 · $23,198

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-22 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −1,239 22,906 D
Loading xslF345X03/doc4.xml…